TY - JOUR
T1 - Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer
AU - Morodomi, Yosuke
AU - Okamoto, Tatsuro
AU - Kohno, Mikihiro
AU - Katsura, Masakazu
AU - Takada, Kazuki
AU - Suzuki, Yuzo
AU - Fujishita, Takatoshi
AU - Kitahara, Hirokazu
AU - Shimamatsu, Shinichiro
AU - Yoshida, Tsukihisa
AU - Tagawa, Tetsuzo
AU - Okano, Shinji
AU - Maehara, Yoshihiko
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Background/Aim: Patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) gene mutations or echinoderm microtubuleassociated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) rearrangement often have a better prognosis when they are treated with specific inhibitors than when treated with cytotoxic agents. However, the associations between gene mutations and cytotoxic chemosensitivity are still unclear. The objective of the present study was to identify which clinicopathological factors, including genetic mutations, influence chemosensitivity, determined using the succinate dehydrogenase inhibition (SDI) test in patients with NSCLC. Materials and Methods: The chemosensitivity of tumor tissues from 96 patients with NSCLC who underwent surgical resection was evaluated using the SDI test. Results: In patients with adenocarcinoma, tumors with EGFR gene mutations were significantly more sensitive to 5-fluorouracil (5-FU) than tumors without EGFR gene mutations (p<0.0149). Conclusion: Our data suggest that patients with adenocarcinoma harboring EGFR gene mutations may be susceptible to 5-FU.
AB - Background/Aim: Patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) gene mutations or echinoderm microtubuleassociated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) rearrangement often have a better prognosis when they are treated with specific inhibitors than when treated with cytotoxic agents. However, the associations between gene mutations and cytotoxic chemosensitivity are still unclear. The objective of the present study was to identify which clinicopathological factors, including genetic mutations, influence chemosensitivity, determined using the succinate dehydrogenase inhibition (SDI) test in patients with NSCLC. Materials and Methods: The chemosensitivity of tumor tissues from 96 patients with NSCLC who underwent surgical resection was evaluated using the SDI test. Results: In patients with adenocarcinoma, tumors with EGFR gene mutations were significantly more sensitive to 5-fluorouracil (5-FU) than tumors without EGFR gene mutations (p<0.0149). Conclusion: Our data suggest that patients with adenocarcinoma harboring EGFR gene mutations may be susceptible to 5-FU.
UR - http://www.scopus.com/inward/record.url?scp=84924980718&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924980718&partnerID=8YFLogxK
M3 - Article
C2 - 25750344
AN - SCOPUS:84924980718
SN - 0250-7005
VL - 35
SP - 1791
EP - 1796
JO - Anticancer Research
JF - Anticancer Research
IS - 3
ER -
